Levine, Deborah JoSchool of Medicine |
|
|
Professor of Medicine in Pulmonary and Critical Care Medicine |
|
| 9/2014 - Present | Professor and Director of Inpatient and Outpatient Lung Transplantation, Director of Pulmonary Hypertension Center | University of Texas Health Science Center, Medicine, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 2003 | Clinical Fellowship | Lung Transplantation/Interventional Pulmonology | UTHSCSA San Antonio , TX |
| 2002 | Clinical Fellowship | Critical Care Medicine | UTHSCSA San Antonio , TX |
| 2001 | Clinical Fellowship | Pulmonary Disease | Good Samaritan/VAMC Phoenix , AZ |
| 1999 | Internship | Internal Medicine | Good Samaritan/VAMC Phoenix , AZ |
| 1996 | MD | Medicine | University of Arizona College of Medicine Tucson , AZ |
| 1992 | MS | Pharmacology/Toxicology | University of Arizona/College of Medicine Tucson , AZ |
| 1991 | BS | Physiology | University of California Davis , CA |
Antibody Mediated Rejection - Lung Transplantation |
Critical Care Medicine- Critical Care Board certification and practice in the medical intensive care unit, transplant intensive care unit and surgical intensive care unit |
Internal Medicine- Boarded in internal medicine |
Interventional Pulmonology- Completed fellowship in interventional pulmonology including 2 week course in Heidelberg Germany |
Lung Transplantation- Lung transplant pulmonologist. Care for all aspects of lung transplant patient: ICU care, donor management, post-lung transplant care in and out of the hospital. |
Organ Donor Management in the ICU- Manage organ donors in the icu prior to procurement. This improves the number of donor numbers so we have increased donor organs for transplant recipients. |
Pulmonary Disease- Pulmonologist involved in clinical, research and teaching at UTHSCSA. |
Pulmonary Hypertension- Medical Director of Pulmonary Hypertension Center: Center has >200 patients I follow regularly. This center is the only one in South Texas and the third biggest center in Texas. |
Abstract |
| Hamandi B, Fegbeutel C, Silveira FP, Verschuuren EA, Younus M, Mo J, Yan J, Ussetti P, Chin-Hong PV, Sole A, Holmes-Liew CL, Billaud EM, Grossi PA, Manuel O, Levine DJ, Barbers RG, Hadjiliadis D, Aram J, Singer LG, Husain S. Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter study. Am J Transplant; 2017 Sep. (Am J Transplant). |
| Riera J, Maldonado C, Mazo C, Martinez M, Baldira J, Lagunes L, Augustin S, Roman A, Due M, Rello J, Levine DJ. Prone positioning as a bridge to recovery from refractory hypoxaemia following lung transplantation; 2017 Aug. (Interact Cardiovasc Thorac Surg). |
| Reinsmoen NL, Mirocha J, Ensor CR,, Marrari M, Chaux G, Levine DJ, Zhang X, Zeevi A. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome; 2017 Jun. (Transplantation). |
| Zamanian RT, Levine DJ, Bourge RC, De Souza SA, Rosenzweig EB, Alnuaimat H, Burger C, Mathai SC, Leedom N, DeAngelis K, Lim A, De Marco T. An observational study of inhaled-treprostinil respiratory-related safety in patients with pulmonary arterial hypertension; 2016 Sep. (Pulmonary Circ). |
| Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D Jr,, Neil D, Reinsmoen NL, Snyder LD, Sweet S, Tyan D,, Verleden G, Westall G, Yusen RD, Zamora M, Zeevi A. Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation; 2016 Apr. (J Heart Lung Transplant). |
| Palacio F, Reyes LF, Levine DJ, Sanchez JF, Angel LF, Fernandez JF, Levine SM, Rello J, Abedi A, Restrepo MI. Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients. Chest; 2015 Aug. (CHEST). |
| Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, Byrnes MC, DeVita MA, Grissom TE, Halpern SD, Nakagawa TA, Stock PG, Sudan DL, Wood KE, Anillo SJ, Bleck TP, Eidbo EE, Fowler RA, Glazier AK, Gries C, Hasz R, Herr D, Khan A, Landsberg D, Lebovitz DJ, Levine DJ, Mathur M, Naik P, Niemann CU, Nunley DR, O'Connor KJ, Pelletier SJ, Rahman O, Ranjan D, Salim A, Sawyer RG, Shafer T, Sonneti D, Spiro P, Valapour M, Vikraman-Sushama D, Whelan TP. Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Donor Management Task Force. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of; 2015 Jun. (Crit Care Med). |
| Levine DJ, Riley DJ, Jorgensen JH, McClain WD, Tio F, Visvesvara GS, Abboud-Werner SL. Key diagnostic features of granulomatous interstitial nephritis due to Encephalitozoon cuniculi in a lung transplant recipient; 2013 Mar. (Am J Surg Pathol). |
| Colman RE, Curtis JR, Nelson JE, Efferen L, Hadjiliadis D, Levine DJ, Meyer KC, Padilla M, Strek M, Varkey B, Singer LG. Barriers to optimal palliative care of lung transplant candidates; 2013 Mar. |
| Burguete SR, Levine SM, Restrepo MI, Angel LF, Levine DJ, Coalson JJ, Peters JI. Lung transplantation for Williams-Campbell syndrome with a probable familial association; 2012 Sep. |
| Cadena J, Levine DJ, Angel LF, Maxwell PR, Brady R, Sanchez JF, Michalek JE, Levine SM, Restrepo MI. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness; 2009 Sep. |
| Angel LF, Levine DJ, Restrepo MI, Johnson S, Sako E, Carpenter A, Calhoon J, Cornell JE, Adams SG, Chisholm GB, Nespral J, Roberson A, Levine SM. Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes; 2006 Jun. (Am J Respir Crit Care Med). |
| Aposhian HV, Maiorino RM, Rivera M, Bruce DC, Dart RC, Hurlbut KM, Levine DJ, Zheng W, Fernando Q, Carter D. et al. Human studies with the chelating agents, DMPS and DMSA. J Toxicol Clin Toxicol; 1992 Feb. |
Journal Article |
| Palacio F, Reyes, Luis F, Levine DJ, Sanchez, Juan F, Angel LF, Fernandez, Juan F, Levine SM, Rello, Jordi, Abedi A, Restrepo MI. Understanding the concept of health care associated pneumonia (HCAP) in lung transplant recipients CHEST 2015 Aug;148(2):516-522. |
| Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel LF, Byrnes MC, DeVita MA, Grissom TE, Halpern SD, Nakagawa TA, Stock PG, Sudan DL, Wood KE, Anillo SJ, Bleck TP, Eidbo EE, Fowler RA, Glazier AK, Gries C, Hasz R, Herr D, Khan A, Landsberg D, Lebovitz DJ, Levine DJ, Mathur M, Naik P, Niemann CU, Nunley DR, O`Connor KJ, Pelletier SJ, Rahman O, Ranjan D, Salim A, Sawyer RG, Shafer T, Sonneti D, Spiro P, Valapour M, Vikraman-Sushama D, Whelan TP. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement Crit Care Med 2015 Jun;43(6):1291-1325. |
| R.R. Hachem, M. Kamoun, M. Budev, M. Askar, A. Vivek, Levine DJ, Pollack MS, Dhillon, K. Schechtman, L.E. Lorriana, L.A. Baxter-Lowe, T. Mohanakumar, D. Tyan, R.D. Yusen. HLA Antibodies After Lung Transplantation: Early results of the HALT Study Journal of Heart and Lung Transplantation 2013 Apr;32(4):S76-S77. |
| Levine DJ, Riley DJ, Jorgensen JH, McClain WD, Tio FO, Visvesvara GS, Abbound-Werner SL. Key diagnostic features of granulomatous interstitial nephritis due to Encephalitozoon cuniculi in a lung transplant recipient Amer. J. Surg. Path 2013 Mar;37:447-452. |
| Levine DJ, Riley DJ, Jorgensen JH, McClain WD, Tio F, Visvesvara GS, Werner SL. Key diagnostic features of granulomatous interstitial nephritis due to Encephlaitozoon cuniculi in a lung transplant recipient Am J Surg Pathol 2013 Mar;37(3):447-452. |
| Levine DJ. Diagnosis and Management of Pulmonary Arterial Hypertension: Implications for Respiratory Care Respiratory Care 2006 Apr;51(4):368-381. |
| Grasseschi RM, Ramaswamy RB, Levine DJ, Klaassen CD, Wesselius LJ. Cadmium accumulation and detoxification by alveolar macrophages of cigarette smokers Chest 2003 Nov;124(5):1924-1928. |
| Aposhian HV, Levine DJ, Rivera M, Fernando Q. Determination and metabolism of dithiol chelating agents: the zinc chelate of the dimethyl ester of meso-2,3-dimercaptosuccinic acid increase biliary excretion of cadmium and platinum 1993 Mar;. |
Not Specified |
| Rivera M, Levine DJ, Aposhian HV, Fernando Q. Synthesis and properties of the monomethyl ester of meso-dimercaptosuccinic acid and its chelates of lead (II), cadmium(II), and mercury(II) Chem Res Toxicol 1991 Jan;4(1):107-114. |
Private |
|
| Funding Agency | |
| Title | The role of C4D staining and donor specific antibodies in Lung Transplant Rejection: A Retrospective Chart Review to evaluate the role of C4D staining and histologic featurers of transplant trans-bronchial biopsies. |
| Status | Active |
| Period | 5/2008 - Present |
| Role | Principal Investigator |
| Grant Detail | |
| Funding Agency | Emphasys, Inc. |
| Title | Endobronchial Valve for Emphysema Palliation Trial - VENT |
| Status | Active |
| Period | 6/2008 - Present |
| Role | Co-Investigator |
| Grant Detail | Goal: To relieve symptoms and improve quality of life of emphysema patients without surgical intervention Evaluate the safety and efficacy of the Emphasys Endobronchial Valve for Emphysema Palliation Trial (VENT) |
| Funding Agency | United Therapeutics |
| Title | ASPIRE: PAH study - A postmarketing observational study to assess respiratory tract adverse events in pulmonary arterial hypertension pstients treated with Tyvaso (Treprostinil) inhalation solution |
| Status | Active |
| Period | 5/2011 - 1/2029 |
| Role | Co-Principal Investigator |
| Grant Detail | PAH study - A postmarketing observational study to assess respiratory tract adverse events in pulmonary arterial hypertension pstients treated with Tyvaso (Treprostinil) inhalation solution |
| Funding Agency | Spiration Inc. |
| Title | A prospective randomized controlled multicenter clinical trial to evaluate the safety and effectiveness of the IBV valve system for the treatment of severe emphysema. |
| Status | Active |
| Period | 7/2005 - 1/2029 |
| Role | Co-Investigator |
| Grant Detail | |
| Funding Agency | Co Therix Inc |
| Title | Registry to EValuate Early and Long-term Pulmonary Arterial Hypertension Disease Management (REVEAL Registry) |
| Status | Active |
| Period | 11/2010 - 1/2019 |
| Role | Principal Investigator |
| Grant Detail | Total funding amount and receipt dependent on participant enrollment. Approved for up to $187,500. Patients are enrolled and updates are done on a quarterly basis for 5 years. There is an annual meeting nationally for centers involved in this area. |
| Funding Agency | UHN Toronto |
| Title | A Multicenter, Multinational, Retrospective Review of Voriconazole Experience for the Prophylaxis against Invasive Aspergillosis in Lung Transplant Recipients |
| Status | Active |
| Period | 10/2012 - Present |
| Role | Principal Investigator |
| Grant Detail | |